Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

LOS ANGELES, Nov. 16, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aurora Cannabis, Inc. ("Aurora"...

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aurora Cannabis, Inc. (ACB)

Over-Allotment Option Exercised in Full Over-Allotment Option Exercised in Full

Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering

NYSE | TSX: ACB EDMONTON, AB, Nov. 16, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) ( TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General and Special Meeting of...

Aurora Announces Results of 2020 Annual General and Special Meeting

Aurora Cannabis and the $2.17 Billion Magic Trick

New York, New York--(Newsfile Corp. - November 13, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the "Class Period"), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.To join the Aurora class action,...

ROSEN, LEADING INVESTOR COUNSEL, Reminds Aurora Cannabis Inc. Investors of Important December 1 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - ACB

Arena Pharmaceuticals

Canopy Growth

HEXO Corp

FSD Pharma

Akerna Corp

OrganiGram Holdings Inc.

SNDL Inc.

Tilray Brands

Village Farms International

cbdMD Inc

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in the upcoming week.

11 Cannabis Stocks Making Moves While Riding the 'Green Wave'

Cronos Group

Green Thumb Industries Inc.

They're kind of getting the cart before the horse.

Here's the Big Mistake Some Marijuana Stock Investors Are Making Right Now

ACB stock soared with the sector after last week's election. But investors have too many far better choices to play cannabis legalization.

Why Aurora Cannabis Is Not the Play on Recent Cannabis Optimism

The flotation will mint at least 20 million fresh shares of the cannabis industry bellwether.

Aurora Cannabis Raising $150 Million in New Share Issue

Aurora really has only itself to blame for this.

Why Aurora Cannabis Stock Is Still Going Down Today

Boeing

Zoom Video

Plug Power

Plug Power, Aurora Cannabis, Boeing and Zoom Video were our top stock trades for Thursday. That said, let's look at the charts.

4 Top Stock Trades for Thursday: ACB, BA, ZM, PLUG

Why Aurora Cannabis, HEXO, and Tilray Stocks Just Crashed

Marijuana stocks are broadly showing signs of life, and ACB stock is no exception to this. Yet, there are reasons to exercise caution now.

Don't Let Political Catalysts Cloud Your Judgment on Aurora Cannabis

Aurora Cannabis Inc. (NYSE: ACB) stock tanked in Wednesday's session on news that the company will raise capital with a secondary offering.

Aurora Cannabis Secondary Offering Has Shares Up in Smoke

EDMONTON, Alberta, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the pricing of its previously announced overnight marketed public offering (the “Offering”) of units of the Company (the “Units”) at a price of US$7.50 per Unit. The underwriters for the Offering have agreed to purchase 20,000,000 Units from the Company for total gross proceeds to the Company of US$150,000,000.

Aurora Cannabis Prices US$150 Million Underwritten Public Offering

Pot stocks have been trading higher on the heels of Joe Biden being announced as the 2020 presidential election winner. The five states that passed legalization for adult-use cannabis and medical cannabis also bolstered the market.

Stock Wars: Aurora Cannabis Vs. Tilray

Aurora Cannabis Inc.'s $125 million equity offering announced late Tuesday may turn out to be a shrewd move, even though it will dilute existing shareholdings, according to Jefferies analyst Owen Bennett. The move is "not that surprising" and allows Aurora to capitalize on the huge gains its stock has enjoyed since Democrat Joe Biden won the 2020 U.S. presidential election.

Aurora Cannabis' $125 million equity offering is "shrewd" but dilutive: Jefferies

Aurora Cannabis Inc ACB -0.06% shares plunged in the after-hours session Tuesday as the company announced plans for a $125 million public offering.

Aurora's Plan For $125M Public Offering Further Tanks Stock

Aurora Cannabis Inc. plans to sell more shares after big gains in recent days, sending the stock price plunging 15% in late trading Tuesday.

Cannabis Watch: Aurora Cannabis plans to sell more stock, and shares are plunging in late trading

EDMONTON, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it will be filing a preliminary prospectus supplement (the “Preliminary Supplement”) to its short form base shelf prospectus dated October 28, 2020 (the “Base Shelf Prospectus”) relating to a proposed overnight marketed public offering (the “Offering”) of units of the Company (the “Units”) at a price of US$7.50 per Unit for total gross proceeds to the Company of approximately US$125 million.

Aurora Cannabis Announces Proposed Public Offering

Earnings are out, and what went up just came back down.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Wilted This Morning

LOS ANGELES, Nov. 10, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Aurora Cannabis, Inc. ("Aurora" or the "Company") (NYSE: ACB) securities between February...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Aurora Cannabis, Inc. (ACB) Investors

New York, New York--(Newsfile Corp. - November 10, 2020) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) between February 13, 2020 and September 4, 2020 (the "Class Period"). The lawsuit filed in the...

DEADLINE FOR ACB INVESTORS: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Aurora Cannabis Inc.

The massive run-up in shares of Canada's Aurora Cannabis Inc. amid hopes the election of Joe Biden as president will advance cannabis reform is looking overdone after the company's quarterly earnings released Monday were underwhelming, Jefferies analyst Owen Bennett wrote in a note. "Aurora's share price as of the time of writing is running up 135% since end of day on Wednesday," said Bennett.

Aurora Cannabis stock rally looking overdone after lackluster earnings: Jefferies

Investors reacted positively to Aurora's better-than-expected Q1 revenue, but there's more to the story.

News for Aurora Cannabis Stock (ACB)